using newly engineered breast cancer cell line models, we identified a (desumoylated) pr-driven gene signature that is present in human tumors and associated with decreased patient survival.
We showed that PR phosphorylation at Ser294 antagonizes PR SUMOy- lation at Lys388 [13].